Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech
The spike-protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has developed different adverse reactions. Still, delirium has not been reported in a low-risk patient, and it is important to consider it and recognize it as a possibility in all severity risk patients. We presen...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
| Series: | APIK Journal of Internal Medicine |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ajim.ajim_66_21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841556583071350784 |
|---|---|
| author | Lilia M. Sierra Galan Raquel Cohen Shaooli |
| author_facet | Lilia M. Sierra Galan Raquel Cohen Shaooli |
| author_sort | Lilia M. Sierra Galan |
| collection | DOAJ |
| description | The spike-protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has developed different adverse reactions. Still, delirium has not been reported in a low-risk patient, and it is important to consider it and recognize it as a possibility in all severity risk patients. We present a 76-year-old male patient who developed delirium after receiving the second dose of the BNT162b2 mRNA vaccine from Pfizer Inc. and BioNTech®. We theorize about the potential pathophysiology mechanisms involved. |
| format | Article |
| id | doaj-art-888cf94921664aca997b63b256dc34c9 |
| institution | Kabale University |
| issn | 2666-1802 2666-1810 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | APIK Journal of Internal Medicine |
| spelling | doaj-art-888cf94921664aca997b63b256dc34c92025-01-07T07:14:00ZengWolters Kluwer Medknow PublicationsAPIK Journal of Internal Medicine2666-18022666-18102025-01-01131757710.4103/ajim.ajim_66_21Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTechLilia M. Sierra GalanRaquel Cohen ShaooliThe spike-protein severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has developed different adverse reactions. Still, delirium has not been reported in a low-risk patient, and it is important to consider it and recognize it as a possibility in all severity risk patients. We present a 76-year-old male patient who developed delirium after receiving the second dose of the BNT162b2 mRNA vaccine from Pfizer Inc. and BioNTech®. We theorize about the potential pathophysiology mechanisms involved.https://journals.lww.com/10.4103/ajim.ajim_66_21adverse reactiondeliriuminterleukinlow-risk patientspike-protein severe acute respiratory syndrome coronavirus 2 vaccine |
| spellingShingle | Lilia M. Sierra Galan Raquel Cohen Shaooli Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech APIK Journal of Internal Medicine adverse reaction delirium interleukin low-risk patient spike-protein severe acute respiratory syndrome coronavirus 2 vaccine |
| title | Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech |
| title_full | Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech |
| title_fullStr | Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech |
| title_full_unstemmed | Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech |
| title_short | Delirium as an Adverse Reaction to BNT162b2 mRNA Vaccine from Pfizer Inc., and BioNTech |
| title_sort | delirium as an adverse reaction to bnt162b2 mrna vaccine from pfizer inc and biontech |
| topic | adverse reaction delirium interleukin low-risk patient spike-protein severe acute respiratory syndrome coronavirus 2 vaccine |
| url | https://journals.lww.com/10.4103/ajim.ajim_66_21 |
| work_keys_str_mv | AT liliamsierragalan deliriumasanadversereactiontobnt162b2mrnavaccinefrompfizerincandbiontech AT raquelcohenshaooli deliriumasanadversereactiontobnt162b2mrnavaccinefrompfizerincandbiontech |